- Q1 2024 Bergenbio ASA Earnings Call TranscriptMay 29, 2024kr14.28 (-1.11%)Earnings
- Q3 2023 Bergenbio ASA Earnings Call TranscriptNov 14, 2023kr18.38 (+1.32%)Earnings
- Q2 2023 Bergenbio ASA Earnings Call TranscriptAug 23, 2023kr11.06 (-11.52%)Earnings
- Q4 2022 Bergenbio ASA Earnings Call TranscriptFeb 16, 2023kr625.94 (+2.84%)Earnings
- Q3 2022 Bergenbio ASA Earnings Call TranscriptNov 15, 2022kr661.34 (-1.73%)Earnings
- Q2 2022 Bergenbio ASA Earnings Call TranscriptAug 23, 2022kr1029.14 (-7.17%)Earnings
- Q1 2022 Bergenbio ASA Earnings Call TranscriptMay 24, 2022kr1342.54 (-5.76%)Earnings
- Bergenbio ASA Strategy Update TranscriptMay 04, 2022
- Q4 2021 Bergenbio ASA Earnings Call TranscriptFeb 16, 2022kr1486.73 (-4.44%)Earnings
- Q3 2021 Bergenbio ASA Earnings Call TranscriptNov 16, 2021kr1723.29 (-0.99%)Earnings
- Q2 2021 Bergenbio ASA Earnings Call TranscriptAug 17, 2021kr1944.31 (-3.68%)Earnings
- Q1 2021 Bergenbio ASA Earnings Call TranscriptMay 19, 2021kr2020.29 (-9.09%)Earnings
- Bergenbio ASA to Discuss Top Line Data From Phase II Trial Assessing Bemcentinib in Hospitalised COVID-19 Patients Call TranscriptMay 18, 2021
- Q4 2020 Bergenbio ASA Earnings Call TranscriptFeb 10, 2021kr2823.23 (-6.30%)Earnings
- Q3 2020 Bergenbio ASA Earnings Call TranscriptNov 17, 2020kr2413.12 (-3.95%)Earnings
- Q2 2020 Bergenbio ASA Earnings Call TranscriptAug 18, 2020kr3030.44 (-3.04%)Earnings
- Q1 2020 Bergenbio ASA Earnings Call TranscriptMay 19, 2020kr3436.22 (-7.01%)Earnings
- Q4 2019 Bergenbio ASA Earnings Call TranscriptFeb 11, 2020kr1653.92 (+11.37%)Earnings
Q1 2020 Bergenbio ASA Earnings Call Transcript
I'll now hand it over to speakers. Please begin.
Hello. Thank you. Good morning. Welcome to BerGenBio's quarter one 2020 report highlights and financials. My name is Richard Godfrey and I'm the CEO of BerGenBio. This morning, I'm joined by Rune Skeie, our CFO; Hani Gabra, our Chief Medical Officer; and James Lorens, our Chief Scientific Officer. I will lead the presentation and then hand over to Rune, Hani, and James to [pivot] questions.
Next slide, please (technical difficulty). BerGenBio is a publicly traded company on the Oslo Stock Exchange, and I should draw your attention to the forward-looking statement in disclosures that we make here.
Next slide please, just by way of reminder of BerGenBio and that sort of overview, BerGenBio remains world leaders in understanding the biology of AXL and its importance in mediating aggressive diseases. AXL is a tyrosine kinase. It mediates its effect by being upregulated. It drives aggressive diseases such as immune evasion, therapy resistant and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)